Aggressive Combination Therapy Reduces Risk of Heart Attack by 80% in People with Rheumatoid Arthritis
American College of Rheumatology (ACR)The use of combination TNF-inhibitor-methotrexate therapy in people with rheumatoid arthritis was associated with a risk of heart attack that was reduced by 80 percent in comparison with those using methotrexate alone, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.